DR. VIJAY GANESH SANKARAN, M.D., PH.D.
Medical Practice at Brookline Ave, Boston, MA
License number
Massachusetts 254221
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
450 Brookline Ave, Boston, MA 02215
Phone
(617) 355-6363
Personal information
See more information about VIJAY GANESH SANKARAN at radaris.comName
Address
Phone
43 Bay State Rd #B, Boston, MA 02215
19 Trowbridge St, Cambridge, MA 02138
25 Custer St, Jamaica Plain, MA 02130
39 Randall Rd, Reading, MA 01867
Professional information
Dr. Vijay G Sankaran, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatric Hematology & Oncology
Age:
44
Address:
450 Brookline Ave, Boston 02215
(617) 355-6363 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
850 Harrison Ave SUITE 5, Boston 02118
(617) 414-5946 (Phone), (617) 414-4541 (Fax)
(617) 355-6363 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
850 Harrison Ave SUITE 5, Boston 02118
(617) 414-5946 (Phone), (617) 414-4541 (Fax)
Languages:
English
Education:
Medical School
Harvard Med Sch
Graduated: 2007
Harvard Med Sch
Graduated: 2007
Modulation Of Bcl11A For Treatment Of Hemoglobinopathies
US Patent:
8383604, Feb 26, 2013
Filed:
Sep 14, 2009
Appl. No.:
13/063524
Inventors:
Stuart H. Orkin - Brookline MA, US
Vijay G. Sankaran - Jamaica Plain MA, US
Vijay G. Sankaran - Jamaica Plain MA, US
Assignee:
Children's Medical Center Corporation - Boston MA
President and Fellows of Harvard College - Cambridge MA
President and Fellows of Harvard College - Cambridge MA
International Classification:
C12N 15/11, C12N 5/071, C07H 21/02, C07K 14/00
US Classification:
514 44A, 536 245, 530385, 435372
Abstract:
The invention relates to methods and uses of modulating fetal hemoglobin expression (HbF) in a hematopoietic progenitor cells via inhibitors of BCL11A expression or activity, such as RNAi and antibodies.
Modulation Of Bcl11A For Treatment Of Hemoglobinopathies
US Patent:
2013012, May 23, 2013
Filed:
Jan 17, 2013
Appl. No.:
13/743399
Inventors:
Stuart H. Orkin - Brookline MA, US
Vijay G. Sankaran - Jamaica Plain MA, US
Vijay G. Sankaran - Jamaica Plain MA, US
Assignee:
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
CHILDREN'S MEDICAL CENTER CORPORATION - Boston MA
International Classification:
C12N 15/113, A61K 35/28, A61K 49/00
US Classification:
424 92, 514 44 A, 424 937, 435 71, 435 611
Abstract:
The invention relates to methods and uses of modulating fetal hemoglobin expression (HbF) in a hematopoietic progenitor cells via inhibitors of BCL11A expression or activity, such as RNAi and antibodies.